Sponsor: 
Merck Sharp & Dohme (Australia)
Administration route: 
Intramuscular injection, Subcutaneous injection
Vaccine group: 

Registered for use in children aged ≥2 years and in adults.

23vPPV — 23-valent pneumococcal polysaccharide vaccine

Each 0.5 mL monodose vial contains:

  • 25 µg each of pneumococcal capsular polysaccharide of serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F
  • 0.25% phenol

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

23vPPV
23-valent pneumococcal polysaccharide vaccine